• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

New approaches to the treatment of depression.

作者信息

Leonard B E

机构信息

Department of Pharmacology, University College Galway, Ireland.

出版信息

J Clin Psychiatry. 1996;57 Suppl 4:26-33.

PMID:8636063
Abstract

This review considers the various modes of action and possible advantages of the different types of second generation antidepressants. The biochemical changes that may be causally related to depression and the mechanisms whereby these changes may be attenuated by antidepressant treatment are briefly considered. Whereas the monoamine theory of depression and the receptor adaptation hypothesis of antidepressant action have been influential in helping to unify the mechanisms of action of antidepressants with the possible pathologic basis of depression, the introduction of novel antidepressants and the development of treatment strategies suggestive of a rapid onset of antidepressant response may initiate a revision of these concepts. The review ends with a consideration of the nonaminergic changes that may be of fundamental importance not only in the pathologic basis of depression but also to the means whereby antidepressants bring about their clinical effects.

摘要

相似文献

1
New approaches to the treatment of depression.
J Clin Psychiatry. 1996;57 Suppl 4:26-33.
2
[Mechanism of action of antidepressants and therapeutic perspectives].[抗抑郁药的作用机制及治疗前景]
Therapie. 2002 Jul-Aug;57(4):385-96.
3
Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.地昔帕明及其他抗抑郁药物对神经递质受体的调节:抗抑郁作用的神经递质受体假说
J Clin Psychiatry. 1984 Oct;45(10 Pt 2):37-45.
4
[Specifics of a dual action: toward new and more effective antidepressants?].[双重作用的细节:迈向新型且更有效的抗抑郁药?]
Encephale. 1999 Jun;25 Spec No 2:5-20; discussion 23-5.
5
The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.血清素-多巴胺相互作用对抗抑郁治疗的快速起效至关重要:抑郁症动物模型的体内研究
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):141-7. doi: 10.1016/j.pnpbp.2003.09.030.
6
Can monoamine-based therapies be improved?基于单胺的疗法能否得到改进?
J Clin Psychiatry. 2002;63 Suppl 2:14-8.
7
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.攻击行为的社会和神经决定因素:血清素、多巴胺和γ-氨基丁酸系统的药物治疗靶点
Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58. doi: 10.1007/s00213-002-1139-6. Epub 2002 Aug 6.
8
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.三种非典型抗抑郁药的作用机制及临床特征:文拉法辛、奈法唑酮、安非他酮。
J Affect Disord. 1998 Dec;51(3):237-54. doi: 10.1016/s0165-0327(98)00222-5.
9
Bupropion: pharmacology and therapeutic applications.安非他酮:药理学与治疗应用
Expert Rev Neurother. 2006 Sep;6(9):1249-65. doi: 10.1586/14737175.6.9.1249.
10
Models of antidepressant action.抗抑郁作用模型。
J Clin Psychiatry. 1999;60 Suppl 14:16-20; discussion 31-5.

引用本文的文献

1
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.选择性 5-羟色胺再摄取抑制剂抗抑郁反应的候选基因。
Neuropsychiatr Dis Treat. 2005 Mar;1(1):17-35. doi: 10.2147/nedt.1.1.17.52301.
2
Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.西酞普兰增强利培酮诱导的大鼠前额叶皮质单胺释放
Psychopharmacology (Berl). 2006 Apr;185(3):274-81. doi: 10.1007/s00213-005-0206-1. Epub 2006 Mar 7.
3
Duloxetine pharmacology: profile of a dual monoamine modulator.度洛西汀药理学:一种双重单胺调节剂的概况。
CNS Drug Rev. 2002 Winter;8(4):361-76. doi: 10.1111/j.1527-3458.2002.tb00234.x.
4
The prevalence and correlates of untreated serious mental illness.未经治疗的严重精神疾病的患病率及其相关因素。
Health Serv Res. 2001 Dec;36(6 Pt 1):987-1007.
5
The GABA(A) receptor complex as a target for fluoxetine action.作为氟西汀作用靶点的γ-氨基丁酸A(GABA(A))受体复合物
Neurochem Res. 1999 Oct;24(10):1271-6. doi: 10.1023/a:1020977123968.
6
Mirtazapine: a review of its use in major depression.米氮平:其在重度抑郁症治疗中的应用综述
Drugs. 1999 Apr;57(4):607-31. doi: 10.2165/00003495-199957040-00010.